Divi's Laboratories Limited
Divi's Laboratories Limited
Share · INE361B01024 (XBOM)
Overview
No Price
Closing Price XBOM 28.01.2026: 6.240,00 INR
28.01.2026 10:00
Current Prices from Divi's Laboratories Limited
ExchangeTickerCurrencyLast TradePriceDaily Change
XNSE: NSE
NSE
DIVISLAB.NS
INR
28.01.2026 10:00
6.188,00 INR
132,00 INR
+2,18 %
XBOM: MSE
MSE
DIVISLAB.BO
INR
28.01.2026 09:59
6.240,00 INR
184,00 INR
+3,04 %
Share Float & Liquidity
Free Float 44,33 %
Shares Float 117,68 M
Shares Outstanding 265,47 M
Invested Funds

The following funds have invested in Divi's Laboratories Limited:

Fund
iShares MSCI India UCITS ETF USD (Acc)
Vol. in million
11.459,01
Percentage (%)
0,98 %
Fund
iShares MSCI EM Islamic UCITS ETF USD (Dist)
Vol. in million
469,76
Percentage (%)
0,44 %
Fund
iShares MSCI EM ex-China UCITS ETF USD (Acc)
Vol. in million
29,79
Percentage (%)
0,18 %
Fund
iShares MSCI EM IMI ESG Screened UCITS ETF USD (Acc)
Vol. in million
1.863,33
Percentage (%)
0,12 %
Fund
iShares MSCI EM IMI ESG Screened UCITS ETF USD (Dist)
Vol. in million
368,08
Percentage (%)
0,12 %
Company Profile for Divi's Laboratories Limited Share
Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs) and intermediates, and nutraceutical ingredients in India, North America, Asia, Europe, and internationally. It also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as other finished forms, including lutein, and vitamins to food, dietary supplement, and feed manufacturers industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. The company was incorporated in 1990 and is headquartered in Hyderabad, India.
AI Analysis of Divi's Laboratories Limited
Click any analysis below to get instant AI insights from finAgent
Latest AI Analyses of Divi's Laboratories Limited
No AI threads available for this company yet.

Company Data

Name Divi's Laboratories Limited
Company Divi's Laboratories Limited
Website https://www.divislabs.com
Primary Exchange XBOM MSE
ISIN INE361B01024
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Kiran Satchandra Divi B. Pharm., M.Pharm
Market Capitalization 1.647 Mrd.
Country India
Currency INR
Employees 9,7 T
Address Divi Towers, 500032 Hyderabad
IPO Date 2003-03-12

Ticker Symbols

Name Symbol
MSE DIVISLAB.BO
NSE DIVISLAB.NS
More Shares
Investors who hold Divi's Laboratories Limited also have the following shares in their portfolio:
Poltreg S.A.
Poltreg S.A. Share
PORTMAN RIDGE FINANCECORP - 6.125% NOTES DUE 2022
PORTMAN RIDGE FINANCECORP - 6.125% NOTES DUE 2022 Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2026